Strategic Partnership Potential sales opportunity with Oragenics, Inc. leveraging DUCK FLATS Pharma’s expertise in IND readiness and clinical trial design for concussion programs.

Nonclinical Focus Target biotech firms needing strategic development plans from mechanism of action to pharmacokinetics, offering a clear path to regulatory packages supporting IND and NDA/CTD filings.

Small Firm Advantage Position the firm as a nimble, specialized partner for startups and mid-size biotech with revenue in the mid single-digit millions seeking accelerated development timelines.

Therapeutic Agnostic Capitalize on capability to support across all therapeutic areas, pursuing opportunities with companies advancing diverse drug or biotechnology candidates.

Credibility Signals Leverage recent press announcing collaboration with Oragenics to approach other biotech firms pursuing FDA IND readiness and early-stage clinical development partnerships.